Linked Life Data

20920772

Source:http://linkedlifedata.com/resource/pubmed/id/20920772

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-10-5
pubmed:databankReference
pubmed:abstractText
Hereditary angioedema (HAE) results from a genetic deficiency of C1-inhibitor. Two similar independent, randomized, saline controlled, double-blind studies were conducted to evaluate the efficacy and safety of recombinant human C1-inhibitor (rhC1INH) as a treatment of acute angioedema attacks in patients with HAE.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1097-6825
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
126
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
821-827.e14
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
pubmed:affiliation
Department of Medicine, University of California San Diego and San Diego VA Healthcare, La Jolla, CA, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't